Published in Acta Ophthalmol (Copenh) on June 01, 1987
Exfoliation syndrome and occludable angles. Trans Am Ophthalmol Soc (1994) 1.30
Pseudoexfoliation and glaucoma in eyes with retinal vein occlusion. Int Ophthalmol (1999) 0.95
Serum homocysteine, vitamin B 12 and folic acid levels in different types of glaucoma. BMC Ophthalmol (2006) 0.93
Analysis of LOXL1 gene variants in Japanese patients with branch retinal vein occlusion. Mol Vis (2011) 0.75
Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature (1996) 7.11
The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity (1998) 5.20
Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor. J Exp Med (1994) 4.91
Aberrant rearrangements contribute significantly to the allelic exclusion of immunoglobulin gene expression. Nature (1981) 4.78
Multidisciplinary rehabilitation for chronic low back pain: systematic review. BMJ (2001) 4.06
Soluble CD4 molecules neutralize human immunodeficiency virus type 1. Nature (1988) 3.63
Specific low-affinity recognition of major histocompatibility complex plus peptide by soluble T-cell receptor. Nature (1992) 3.36
Myeloma based expression system for production of large mammalian proteins. Trends Biotechnol (1991) 2.82
Multidisciplinary bio-psycho-social rehabilitation for chronic low back pain. Cochrane Database Syst Rev (2002) 2.65
Crystal structure of the beta chain of a T cell antigen receptor. Science (1995) 2.37
Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med (1997) 2.33
Incidence of loss of vision in the healthy eye in amblyopia. Br J Ophthalmol (1981) 2.29
Inherited immunoglobulin idiotypes of the mouse. Immunol Rev (1977) 2.29
Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules. Nature (1989) 2.17
Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J Immunol (2000) 1.68
Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. Immunity (1998) 1.68
Diagnosis and clinical characteristics of ocular Lyme borreliosis. Am J Ophthalmol (1995) 1.65
Orbital germ cell tumors revisited: a clinicopathological approach to classification. Surv Ophthalmol (1994) 1.59
Inheritance of antibody specificity V. Anti-2-phenyloxazolone in the mouse. J Exp Med (1978) 1.55
Anti-oxazolone hybridomas and the structure of the oxazolone idiotype. J Immunol (1983) 1.52
Management of traumatic hyphema in children. An analysis of 340 cases. Arch Ophthalmol (1988) 1.43
Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci (2001) 1.41
A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II. J Exp Med (1998) 1.39
Occlusion of the central retinal artery and retinal branch arterioles. A clinical, tonographic and fluorescein angiographic study of 175 patients. Acta Ophthalmol Suppl (1971) 1.37
Molecular, cellular, and functional properties of bone marrow T lymphocyte progenitor clones. J Exp Med (1987) 1.33
Surface expression of the beta T cell receptor (TCR) chain in the absence of other TCR or CD3 proteins on immature T cells. EMBO J (1991) 1.30
A new mouse TCR V gamma gene that shows remarkable evolutionary conservation. EMBO J (1987) 1.29
Normal T cell development is possible without 'functional' gamma chain genes. EMBO J (1986) 1.29
A mendelian idiotype is demonstrable in the heteroclitic anti-NP antibodies of the mouse. Eur J Immunol (1978) 1.29
Retinoblastoma in Finland 1912-1964. Acta Ophthalmol (Copenh) (1971) 1.27
Thymocyte clones from 14-day mouse embryos. I. State of T cell receptor genes, surface markers, and growth requirements. J Exp Med (1987) 1.18
Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas. J Natl Cancer Inst (1999) 1.17
Prognosis of conjunctival melanomas in relation to histopathological features. Br J Cancer (1989) 1.16
Superantigen binding to a T cell receptor beta chain of known three-dimensional structure. J Exp Med (1995) 1.16
Epidermal growth factor is a constant component of normal human tear fluid. Graefes Arch Clin Exp Ophthalmol (1989) 1.14
A novel approach for preparing anti-T cell receptor constant region antibodies. Eur J Immunol (1986) 1.13
Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cells. EMBO J (1991) 1.13
Muscle-eye-brain disease: a neuropathological study. Ann Neurol (1997) 1.12
Evaluating cataract surgery gains by assessing patients' quality of life using the VF-7. J Cataract Refract Surg (1999) 1.11
Signals through T cell receptor-zeta chain alone are insufficient to prime resting T lymphocytes. J Exp Med (1995) 1.07
Coat's disease: clinical, angiographic, histopathological findings and clinical management. Br J Ophthalmol (1983) 1.07
Role of the T cell receptor ligand affinity in T cell activation by bacterial superantigens. J Biol Chem (2001) 1.05
Role of the T cell receptor alpha chain in stabilizing TCR-superantigen-MHC class II complexes. Immunity (1999) 1.04
Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci (1999) 1.02
Ocular amyloid deposition in familial amyloidosis, Finnish: an analysis of native and variant gelsolin in Meretoja's syndrome. Invest Ophthalmol Vis Sci (1994) 1.02
Screening for colorectal carcinoma in cancer family syndrome kindreds. Scand J Gastroenterol (1987) 1.01
Inheritance of antibody specificity. IV. Control of related molecular species by one VH gene. Cold Spring Harb Symp Quant Biol (1977) 1.00
Concentrations of three hapten-binding immunoglobulins in pooled normal human serum. Eur J Immunol (1976) 0.99
Solubilizing the T-cell receptor--problems in solution. Immunol Today (1989) 0.99
Postural variations of the intraocular pressure as measured with the Mackay-Marg tonometer. Acta Ophthalmol (Copenh) (1967) 0.99
Periodontal disease related to diabetic status. A pilot study of the response to periodontal therapy in type 1 diabetes. J Clin Periodontol (1997) 0.99
Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma. Br J Ophthalmol (1996) 0.98
WITHDRAWN: Multidisciplinary bio-psycho-social rehabilitation for chronic low-back pain. Cochrane Database Syst Rev (2007) 0.97
Two major idiotypes in mouse anti-(4-hydroxy-3-nitro-phenyl)acetyl (NP) antibodies are controlled by "allelic" genes. Eur J Immunol (1980) 0.97
Mouse CD4 binds MHC class II with extremely low affinity. Int Immunol (1993) 0.97
TARPP, a novel protein that accompanies TCR gene rearrangement and thymocyte education. Eur J Immunol (2001) 0.96
Plasmin in tear fluid of patients with corneal ulcers: basis for new therapy. Acta Ophthalmol (Copenh) (1987) 0.95
The T-cell receptor for antigen in T-cell development and repertoire selection. Immunol Rev (1988) 0.95
Histopathologic and immunohistochemical analysis of the filtration bleb after unsuccessful glaucoma seton implantation. Am J Ophthalmol (1996) 0.94
Expression of tenascin and cellular fibronectin in the rabbit cornea after anterior keratectomy. Immunohistochemical study of wound healing dynamics. Invest Ophthalmol Vis Sci (1991) 0.94
Rearrangements of T cell receptor loci can be found only rarely in B lymphoid cells. Eur J Immunol (1986) 0.94
A transcriptional enhancer of the mouse T cell receptor delta gene locus. Eur J Immunol (1991) 0.94
Cytoskeleton in normal and reactive human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (1991) 0.94
In vivo-matured Langerhans cells continue to take up and process native proteins unlike in vitro-matured counterparts. J Immunol (2001) 0.93
Driving gene expression specifically in dendritic cells. Adv Exp Med Biol (1997) 0.92
The Merkel cell and associated neoplasms in the eyelids and periocular region. Surv Ophthalmol (1991) 0.92
Chronic bilateral keratitis in autoimmune polyendocrinopathy-candidiadis-ectodermal dystrophy (APECED). A long-term follow-up and visual prognosis. Acta Ophthalmol Scand (2000) 0.91
New simplified molecular design for functional T cell receptor. Eur J Immunol (1993) 0.91
Epidermal growth factor (EGF) in ocular fluids: presence, origin and therapeutical considerations. Acta Ophthalmol Suppl (1992) 0.90
Failure to demonstrate public idiotypes on cytolytic cells with specificity for NP-coupled syngeneic cells. Scand J Immunol (1980) 0.89
Prospective evaluation of external ocular microbial growth and aqueous humor contamination during cataract surgery. J Cataract Refract Surg (1999) 0.89
Intermediate filaments in the human retina and retinoblastoma. An immunohistochemical study of vimentin, glial fibrillary acidic protein, and neurofilaments. Invest Ophthalmol Vis Sci (1986) 0.89
Comparison of incentive spirometry and intermittent positive pressure breathing after coronary artery bypass graft. Chest (1991) 0.88
Adoptive tumor immunity mediated by lymphocytes bearing modified antigen-specific receptors. Adv Immunol (1998) 0.88
Corneal pathology and outcome of keratoplasty in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Acta Ophthalmol Scand (2001) 0.88
Ultrasonographic biometry in congenital glaucoma. Acta Ophthalmol (Copenh) (1983) 0.88
Neuronal and glial properties of a murine transgenic retinoblastoma model. Am J Pathol (1991) 0.88
A response calculus for immobilized T cell receptor ligands. J Biol Chem (2001) 0.88
Surface-associated activation of plasminogen on gram-positive bacteria. Effect of plasmin on the adherence of Staphylococcus aureus. Acta Ophthalmol Suppl (1992) 0.88
Glioneuroma associated with colobomatous dysplasia of the anterior uvea and retina. A case simulating medulloepithelioma. Ophthalmology (1989) 0.88
Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy. Ophthalmic Surg (1993) 0.87
Binding of fluorescein isothiocyanate conjugated lectins to rat spermatogenic cells in tissue sections. Enhancement of lectin fluorescence obtained by fixation in Bouin's fluid. Histochemistry (1984) 0.87
Cataract and pseudoexfoliation. A clinicopathological study. Acta Ophthalmol (Copenh) (1978) 0.87
Immunohistochemical analysis of lattice corneal dystrophies types I and II. Br J Ophthalmol (1993) 0.87
Cellular fibronectin and tenascin in an orbital nylon prosthesis removed because of infection caused by Staphylococcus aureus. Graefes Arch Clin Exp Ophthalmol (1993) 0.86
Soluble mouse major histocompatibility complex class II molecules produced in Drosophila cells. Eur J Immunol (1995) 0.86
Alveolar bone loss in type 1 diabetic subjects. J Clin Periodontol (2000) 0.86
Neurilemmoma of the choroid in Recklinghausen's disease. Acta Ophthalmol Suppl (1974) 0.86
[Corticosteroids and hemorrhagic glaucoma after central venous occlusion]. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1967) 0.86
Family study of pseudoexfoliation and glaucoma. Acta Ophthalmol (Copenh) (1965) 0.85
Kinetics of generation and persistence on membrane class II molecules of a viral peptide expressed on foreign and self proteins. J Immunol (1996) 0.85
Excess of cancer deaths in close relatives of patients with bilateral retinoblastoma. Ophthalmologica (1984) 0.85
Fine-needle aspiration biopsy in the diagnosis of orbital tumours. Graefes Arch Clin Exp Ophthalmol (1982) 0.85
Wound healing of the ocular surface. Ann Med (1992) 0.85
Two str1cturally similar haptens each induce a different inherited idiotype. Eur J Immunol (1977) 0.84
Synaptophysin in the human retina and retinoblastoma. An immunohistochemical and Western blotting study. Invest Ophthalmol Vis Sci (1989) 0.84
Impaired NK1.1 T cell development in mice transgenic for a T cell receptor beta chain lacking the large, solvent-exposed cbeta FG loop. J Exp Med (1999) 0.84
Targeted expression of MHC class II genes to dendritic cells in vivo. Immunol Lett (1997) 0.84